Catalyst Wire Dossier Catalyst Wire Dossier

BUSULFAN

Busulfan · Accord Healthcare, Inc
Drug timelines are a Plus or Pro feature.

168 regulatory and trial events tracked for BUSULFAN, covering 2008-12-09 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide [EARLY_Phase 1]

See pricing